Switch theme
Sign up to access all valuation multiples
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up roughly 40% of Viatris' total sales. Remaining 60% of sales is derived from its portfolio of legacy products which includes Lipitor, Norvasc, Lyrica, and Viagra. While it covers more than 10 major therapeutic areas, Viatris has identified dermatology, ophthalmology, and gastroenterology as its three key areas of focus for future innovations.
2014
32K+
LTM Revenue $14.5B
LTM EBITDA $4.5B
$22.3B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
Viatris has a last 12-month revenue of $14.5B and a last 12-month EBITDA of $4.5B.
In the most recent fiscal year, Viatris achieved revenue of $14.7B and an EBITDA of $2.8B.
Viatris expects next 12-month revenue of XXX and NTM EBITDA of XXX
See Viatris valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $15.4B | $14.7B | XXX | XXX | XXX |
| Gross Profit | $6.5B | $6.4B | XXX | XXX | XXX |
| Gross Margin | 42% | 44% | XXX | XXX | XXX |
| EBITDA | $3.5B | $2.8B | XXX | XXX | XXX |
| EBITDA Margin | 23% | 19% | XXX | XXX | XXX |
| Net Profit | $2.1B | $54.7M | XXX | XXX | XXX |
| Net Margin | 13% | 0% | XXX | XXX | XXX |
| Net Debt | $18.0B | $17.1B | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, Viatris's stock price is $8.
Viatris has current market cap of $9.1B, and EV of $22.3B.
See Viatris trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $22.3B | $9.1B | XXX | XXX | XXX | XXX | $2.53 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, Viatris has market cap of $9.1B and EV of $22.3B.
Viatris's trades at 1.5x LTM EV/Revenue multiple, and 5.0x LTM EBITDA.
Analysts estimate Viatris's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for Viatris and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $22.3B | XXX | XXX | XXX |
| EV/Revenue | 1.5x | XXX | XXX | XXX |
| EV/EBITDA | 7.9x | XXX | XXX | XXX |
| P/E | -14.4x | XXX | XXX | XXX |
| P/E/Growth | n/a | XXX | XXX | XXX |
| EV/FCF | 11.5x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpViatris's NTM/LTM revenue growth is -4%
Viatris's revenue per employee for the last fiscal year averaged $0.5M, while opex per employee averaged $0.2M for the same period.
Over next 12 months, Viatris's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate Viatris's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for Viatris and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | -4% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 19% | XXX | XXX | XXX | XXX |
| EBITDA Growth | -20% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 15% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.5M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.2M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | 5% | XXX | XXX | XXX | XXX |
| Opex to Revenue | 36% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Julphar | XXX | XXX | XXX | XXX | XXX | XXX |
| Galapagos | XXX | XXX | XXX | XXX | XXX | XXX |
| Pharming | XXX | XXX | XXX | XXX | XXX | XXX |
| Vivoryon Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| Armata Pharmaceuticals | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Viatris acquired XXX companies to date.
Last acquisition by Viatris was XXXXXXXX, XXXXX XXXXX XXXXXX . Viatris acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was Viatris founded? | Viatris was founded in 2014. |
| Where is Viatris headquartered? | Viatris is headquartered in United States of America. |
| How many employees does Viatris have? | As of today, Viatris has 32K+ employees. |
| Who is the CEO of Viatris? | Viatris's CEO is Mr. Scott A. Smith. |
| Is Viatris publicy listed? | Yes, Viatris is a public company listed on NAS. |
| What is the stock symbol of Viatris? | Viatris trades under VTRS ticker. |
| When did Viatris go public? | Viatris went public in 1986. |
| Who are competitors of Viatris? | Similar companies to Viatris include e.g. Julphar, Galapagos, Pharming, Vivoryon Therapeutics. |
| What is the current market cap of Viatris? | Viatris's current market cap is $9.1B |
| What is the current revenue of Viatris? | Viatris's last 12-month revenue is $14.5B. |
| What is the current EBITDA of Viatris? | Viatris's last 12-month EBITDA is $4.5B. |
| What is the current EV/Revenue multiple of Viatris? | Current revenue multiple of Viatris is 1.5x. |
| What is the current EV/EBITDA multiple of Viatris? | Current EBITDA multiple of Viatris is 5.0x. |
| What is the current revenue growth of Viatris? | Viatris revenue growth between 2023 and 2024 was -4%. |
| Is Viatris profitable? | Yes, Viatris is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
